Gabriel Wiedenhoever on Drug Pricing

Washington Healthcare Update - August 2024 #2

This Week in Washington: Congress remains in recess....more

8/27/2024 / Drug Pricing , Health Care Providers , Medicaid , Medicare , Physician Fee Schedule , Section 340B , Telehealth

Washington Healthcare Update - July 2024 #2

This Week in Washington: House Appropriations Committee marks up FY2025 Labor-HHS-Education and the Agriculture- FDA and Related Agencies funding bills; Senate Appropriations Committee marks up FY2025 Agriculture-FDA and...more

7/17/2024 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , Medicare , Proposed Rules , SAMHSA

Rep. Bucshon Introduces Latest 340B Legislation in the House

On May 28, 2024, Rep. Larry Bucshon (R-IN) introduced the “340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act.” This legislation is the latest bill introduced in the House attempting to clarify...more

6/11/2024 / Department of Health and Human Services (HHS) , Drug Pricing , Pharmaceutical Industry , Prescription Drugs , Section 340B

Washington Healthcare Update - May 2024

This Week in Washington: Senate Finance Committee releases discussion draft concerning generic drug shortages; FDA releases laboratory-developed tests final rule; Administration extends ACA subsidies for Deferred Action for...more

5/7/2024 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicaid , Medicare , Prescription Drugs , Proposed Rules

Washington Healthcare Update - February 2024

This Week in Washington: CMS releases 2025 MA and Part D proposed payment Advance Notice; CMS sends first fair drug price offers to Drug Price Negotiation Program companies; SAMHSA releases final rule making virtual...more

2/8/2024 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicaid , Medicare , Popular , Prescription Drugs , Proposed Rules

Washington Healthcare Update - December 2023 #3

This Week in Washington: House passes Lower Costs, More Transparency Act and SUPPORT Act Reauthorization; Senate HELP Committee reports SUPPORT Act Reauthorization and three other bills out of committee; ONC releases final...more

12/19/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare Part B , Medicare Part D , Prescription Drugs , Proposed Rules , Vaccinations

Washington Healthcare Update - November 2023

This Week in Washington: Senate Finance Committee releases discussion draft for Nov. 8 markup; White House issues executive order on AI; House passes two appropriations bills; Senate passes minibus....more

11/7/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , Medicare , Physician Fee Schedule , Popular , Prescription Drugs , Proposed Rules

Washington Healthcare Update - July 2023 #2

This Week in Washington: House Energy and Commerce Committee marks up 15 healthcare bills; Senate HELP Committee to hold mark up on primary care bill; CMS concerned over procedural Medicaid coverage terminations...more

7/25/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , Proposed Rules , SAMHSA

Washington Healthcare Update - June 2023 #4

This Week in Washington: Senate Appropriations Committee meets to figure out top-line numbers; Majority Leader Schumer leads Senate in developing a policy response to artificial intelligence; and CMS proposes new Medicare...more

6/27/2023 / Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Washington Healthcare Update - June 2023 #3

This Week in Washington: FDA funding bill passes House Appropriations Committee, MedPAC and MacPAC release June 2023 report to Congress, RSC budget blueprint brings back premium support concept for Medicare...more

6/21/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , Medicare , Pharmaceutical Industry , Prescription Drugs , Proposed Rules

Washington Healthcare Update - June 2023 #2

This Week in Washington: Fallout from debt ceiling holds up House floor action; SCOTUS rules to allow patients to sue nursing homes...more

6/13/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicaid , Prescription Drugs , Proposed Rules

Washington Healthcare Update - May 2023 #3

This Week in Washington: President and Speaker McCarthy to meet on debt limit with 10 days to go, House Energy and Commerce Subcommittee on Health marks up 17 bills, House Appropriations Committee begins moving appropriation...more

5/23/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Popular , Prescription Drugs , Proposed Rules

Washington Healthcare Update - April 2023 #3

This Week in Washington: House Republicans release debt ceiling plan, Speaker McCarthy moves forward with proposal that includes Medicaid work requirements...more

4/25/2023 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Final Rules , Food and Drug Administration (FDA) , GAO , Medicare , Prescription Drugs , Proposed Rules